Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04272060 · ClinicalTrials.gov registry record · NA

Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease

A NA study of Coronary Artery Disease, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04272060: Completed NA study of Coronary Artery Disease, sponsored by Johns Hopkins University.

NCT04272060 is a NA study of Coronary Artery Disease that has completed, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04272060, a NA study of Coronary Artery Disease, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart disease (CHD). However, cardiac catheterization is costly and, as an invasive procedure, it is associated with some risk of adverse events, rarely even stroke, myocardial infarction, or death. Recent advances in multi-detector computed tomography angiography (CTA) have allowed rapid, noninvasive coronary artery imaging in patients with suspected CHD. CTA generally yields high accuracy for identifying patients with CHD when compared to cardiac catheterization. However, diagnostic accuracy is reduced in the setting of severe coronary artery calcification and coronary stents due to its inferior spatial resolution compared to cardiac catheterization. Because high-risk patients often have severe coronary calcification or stents, the application of CTA has been particularly limited in this important patient group. Recently, an ultrahigh-resolution CT scanner was released which has shown promise to overcome the limitation of conventional CTA in the setting of severe coronary artery calcification or stents. This ultrahigh-resolution "precision" CT scanner (UHR-CT) contains detector rows with half the width than currently available systems (0.25 mm vs. 0.5 mm) resulting in approximately twice the spatial resolution. The purpose of this investigation is to test the hypothesis that high-resolution CTA is not inferior to the current standard of cardiac catheterization for identifying significant CHD in patients with high-risk characteristics, including severe coronary artery calcification and coronary stents. The investigators propose to enroll 50 patients over 24-30 months in this investigation as part of a multicenter study. Patients referred for cardiac catheterization with known CHD and suspected obstructive coronary artery stenosis will be included. All patients will undergo both cardiac catheterization and UHR-CT for deter

Primary Outcome

The primary outcome was the patient-level diagnostic accuracy of ultra-high-resolution computed tomography (UHR-CT) compared with invasive coronary angiography (ICA) for identifying hemodynamically significant coronary artery disease (CAD), using quantitative flow ratio (QFR ≤0.80) as the reference standard. For each patient, the highest-grade stenosis across all coronary vessels determined by UHR-CT and ICA was used to classify the test result. Diagnostic accuracy was defined as the percentage

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST CT angiography
  • DIAGNOSTIC_TEST Invasive coronary angiography

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-11-22
Est. Completion 2025-07-31
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT04272060 record still lists

NCT04272060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which CT angiography is the first listed.

NCT04272060 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04272060 about?

NCT04272060 is a clinical study titled "Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease". Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart disease (CHD). However, cardiac catheterization is costly and, as an invasive procedure, it is associated with some risk of adverse events, rarely eve...

What is the current status of trial NCT04272060?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-11-22. Estimated completion is 2025-07-31.

What conditions does trial NCT04272060 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT04272060?

The interventions under investigation include: CT angiography (DIAGNOSTIC_TEST), Invasive coronary angiography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04272060?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04272060 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04272060's enrollment target sits among peer trials

80 158th of 219 higher than 61 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04272060, the US trial registry maintained by the National Library of Medicine. NCT04272060 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.